APOL1-mediated kidney disease
Every day, people living with serious diseases strive to be more than their disease — to be defined by what they can dream and hope and achieve, not by what limits them. Our commitment to people with serious diseases is uncompromising and goes beyond our R&D and medicines.
Working with the APOL1-mediated kidney disease community
We are proud to work with organizations that help people with APOL1-mediated kidney disease live active, full lives.
We are committed to investigating and advancing potential therapies to treat patients living with APOL1-mediated kidney disease. Vertex seeks to identify opportunities where we can support, empower, learn from and engage with the kidney disease community, and ensure their voices are represented and incorporated into all that we do.
Supporting kidney disease community partners
We are proud to work with and support many organizations in the kidney community, including:
We've had the privilege to support patient advocacy group efforts to advance health equity in kidney disease, and to raise awareness of APOL1-mediated kidney disease, through sponsorships of NephCure and AKF. Through sponsorships of NKF’s Genetic Testing workshop and AKF’s Unknown Cause of Kidney Disease campaign, we are helping to drive more precise kidney diagnoses.
We're also proud to be an inaugural supporter of the Rare Disease Diversity Coalition, which brings together rare disease experts, health and diversity advocates, and industry leaders to identify and advocate for evidence-based solutions to help alleviate the disproportionate burden of rare diseases on communities of color.
Our work in APOL1-mediated kidney disease
Click here to learn about our research in APOL1-mediated kidney disease.
To learn more about our studies, please visit the clinical trials website or EU Clinical Trials Register.